XML 76 R65.htm IDEA: XBRL DOCUMENT
v3.19.3

Business Combination - Schedule of Unaudited Pro Forma Statements of Operations (Details) - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended
--- | --- | --- | ---
Jun. 30, 2018 | Jun. 30, 2018 | Dec. 31, 2018 | Dec. 31, 2017
Revenue | $ 1,515,588 | $ 3,013,723 | $ 5,823,996 | $ 5,565,194
Net Income (Loss) | $ 8,328 | $ 167,582 | $ 118,903 | $ 225,851
Net Income per common share - basic | $ 0.00 | $ 0.01 | $ 0.00 | $ 0.01
Net Income per common share - diluted | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.01
Weighted average common shares - basic | 31,985,827 | 31,985,827 | 32,260,622 | 31,955,416
Weighted average common shares - diluted | 34,479,406 | 34,472,811 | 34,958,502 | 34,086,251
Trxade [Member] |  |  |  |
Revenue | $ 837,688 | $ 1,690,611 | $ 3,436,360 | $ 2,931,280
Net Income (Loss) | $ 20,513 | $ 102,782 | $ 125,626 | $ 288,983
Net Income per common share - basic | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.01
Net Income per common share - diluted | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.01
Weighted average common shares - basic | 31,985,827 | 31,985,827 | 32,260,622 | 31,955,416
Weighted average common shares - diluted | 34,479,406 | 34,472,811 | 34,958,502 | 34,086,251
Community Specialty Pharmacy, LLC [Member] |  |  |  |
Revenue | $ 677,900 | $ 1,323,117 | $ 2,387,636 | $ 2,633,914
Net Income (Loss) | $ (12,185) | $ 64,800 | $ (6,723) | $ (63,132)

X
- Definition The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasic
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaEarningsPerShareDiluted
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(3) -URI http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionsProFormaRevenue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The weighted average number of shares or units and dilutive common stock or unit equivalents outstanding in the calculation of proforma diluted earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering. + References No definition available. + Details
Name: | us-gaap_ProFormaWeightedAverageSharesOutstandingDiluted
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average number of shares (units) outstanding in the calculation of pro forma basic earnings per share (earnings per unit), which is commonly presented in initial public offerings based on the terms of the offering. + References No definition available. + Details
Name: | us-gaap_WeightedAverageBasicSharesOutstandingProForma
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | dei_LegalEntityAxis=TRXD_TrxadeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=TRXD_CommunitySpecialtyPharmacyLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |